Tickerplace logo

Tickerplace

Cogent Biosciences, Inc. logo

COGTCogent Biosciences, Inc.

COGT Stock Price, Valuation & Chart | Cogent Biosciences, Inc.

Compare
$29.520+0.01 (+0.03%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

COGT Historical price chart

COGT Key Stats

Market Capitalization5.12B
PE Ratio-13.99
EPS-2.11
Trading Volume2.78M
Today's High/Low29.97/28.77
Dividend Yield0.00
52 Week High/Low43.73/13.78
Shares Outstanding173.52M
COGT Financial Statement
COGT Analyst ratings
COGT Analysis & performance metrics

COGT Company profile

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a…

COGT Management team

Management
John L. Green C.A., CPACFO
Chief Financial Officer & Principal Accounting Officer
Jessica Sachs M.D.
Chief Medical Officer
Evan D. Kearns J.D.
Chief Legal Officer & Corporate Secretary
Dana R. Martin Pharm.D.
Senior Vice President of Medical Affairs & Chief Patient Officer
Erin Schellhammer
Chief People Officer
Andrew R. Robbins M.B.A.CEO
President, Chief Executive Officer & Director
Christi WaarichCTO
Senior Director of Investor Relations
John Edward Robinson Ph.D.
Chief Scientific Officer
Total 8 executives

COGT Frequently asked questions

What is Cogent Biosciences, Inc. (COGT) Stock Price?

Current stock price of Cogent Biosciences, Inc. (COGT) stock is $29.520. The stock price is +0.03% higher in the session. The intraday range can be seen from this page. Volume of Cogent Biosciences, Inc. (COGT) stock is 2.78M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Cogent Biosciences, Inc. (COGT) stock price going up or down today?

The stock price of Cogent Biosciences, Inc. (COGT) can change with earnings, company news, and overall market sentiment. Cogent Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cogent Biosciences, Inc. stock expensive at its current price?

Whether Cogent Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for COGT on this page is -13.99. EPS on this page is -2.11. Compare those figures with peers and growth expectations before deciding if the current Cogent Biosciences, Inc. price is justified.

How has the stock price of Cogent Biosciences, Inc. (COGT) performed historically?

Historical performance for Cogent Biosciences, Inc. (COGT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how COGT reacted to past earnings and market events.

Should I buy Cogent Biosciences, Inc. (COGT) stock, at this price?

Buying Cogent Biosciences, Inc. (COGT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.